Robert A. Beardsley - 21 Nov 2022 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Chief Operating Officer
Signature
/s/ Christopher Degnan, Attorney-in-Fact for Robert A. Beardsley
Issuer symbol
GRTX
Transactions as of
21 Nov 2022
Net transactions value
+$10,700
Form type
4
Filing time
22 Nov 2022, 15:05:13 UTC
Previous filing
13 Sep 2022
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRTX Common Stock Options Exercise $10,700 +10,000 +10% $1.07* 108,191 21 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option Options Exercise $0 -10,000 -12% $0.000000 75,651 21 Nov 2022 Common Stock 10,000 $1.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option has fully vested and is currently exercisable.